Research Article Development and Validation of a Stability Indicating
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Effect of 10 UV Filters on the Brine Shrimp Artemia Salina and the Marine Microalgae Tetraselmis Sp
bioRxiv preprint doi: https://doi.org/10.1101/2020.01.30.926451; this version posted January 31, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Effect of 10 UV filters on the brine shrimp Artemia salina and the marine microalgae Tetraselmis sp. Evane Thorel, Fanny Clergeaud, Lucie Jaugeon, Alice M. S. Rodrigues, Julie Lucas, Didier Stien, Philippe Lebaron* Sorbonne Université, CNRS USR3579, Laboratoire de Biodiversité et Biotechnologie Microbienne, LBBM, Observatoire Océanologique, 66650, Banyuls-sur-mer, France. *corresponding author : E-mail address : [email protected] Abstract The presence of pharmaceutical and personal care products’ (PPCPs) residues in the aquatic environment is an emerging issue due to their uncontrolled release, through grey water, and accumulation in the environment that may affect living organisms, ecosystems and public health. The aim of this study is to assess the toxicity of benzophenone-3 (BP-3), bis-ethylhexyloxyphenol methoxyphenyl triazine (BEMT), butyl methoxydibenzoylmethane (BM), methylene bis- benzotriazolyl tetramethylbutylphenol (MBBT), 2-Ethylhexyl salicylate (ES), diethylaminohydroxybenzoyl hexyl benzoate (DHHB), diethylhexyl butamido triazone (DBT), ethylhexyl triazone (ET), homosalate (HS), and octocrylene (OC) to marine organisms from two major trophic levels including autotrophs (Tetraselmis sp.) and heterotrophs (Artemia salina). In general, EC50 results show that both HS and OC are the most toxic for our tested species, followed by a significant effect of BM on Artemia salina but only at high concentrations (1 mg/L) and then an effect of ES, BP3 and DHHB on the metabolic activity of the microalgae at 100 µg/L. -
WO 2013/036901 A2 14 March 2013 (14.03.2013) P O P C T
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2013/036901 A2 14 March 2013 (14.03.2013) P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 8/30 (2006.01) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (21) International Application Number: BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, PCT/US2012/054376 DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (22) International Filing Date: HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, 10 September 2012 (10.09.2012) KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, (25) Filing Language: English NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, (26) Publication Language: English RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, (30) Priority Data: ZM, ZW. 61/532,701 9 September 201 1 (09.09.201 1) US (84) Designated States (unless otherwise indicated, for every (71) Applicant (for all designated States except US): UNIVER¬ kind of regional protection available): ARIPO (BW, GH, SITY OF FLORIDA RESEARCH FOUNDATION, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, INC. -
Les Filtres UV Dans Les Cosmétiques : Une Présence Obligatoire ?
UNIVERSITÉ DE NANTES UFR SCIENCES PHARMACEUTIQUES ET BIOLOGIQUES ____________________________________________________________________________ ANNÉE 2015 N° THÈSE pour le DIPLÔME D’ÉTAT DE DOCTEUR EN PHARMACIE par Anouk POCHAT Présentée et soutenue publiquement le 14 décembre 2015 Les filtres UV dans les cosmétiques : une présence obligatoire ? Président : Mme Laurence Coiffard, Professeur des universités, Laboratoire de Pharmacie industrielle et Cosmétologie Membres du jury : Directeur de thèse : Mme Céline Couteau, Maître de conférences, HDR, Laboratoire de Pharmacie industrielle et Cosmétologie Mme Françoise PEIGNE , Maitre de conférences à la retraite Page 1 Remerciements A mon président de jury, Professeur à la faculté des sciences pharmaceutiques de Nantes J’exprime mes profonds remerciements à Mme Coiffard, pour m’avoir fait l’honneur de présider mon jury de thèse. A mon directeur de thèse, Maître de conférences à la faculté de Pharmacie de Nantes Je remercie Mme Couteau pour m’avoir conseillée et guidée tout au long de mon travail. A Madame Françoise PEIGNE, Docteur en Pharmacie, Je remercie Mme Peigné d’avoir accepté d’assister à ma soutenance. A ma mère, Je te remercie de m’avoir soutenue et encouragée tout au long de mes études. A mon conjoint, Je te remercie pour ta patience, ton écoute et ton soutien. A mes frères, Je vous remercie pour vos encouragements Page 2 I.Introduction Une exposition prolongée aux UVA et aux UVB peut avoir de graves conséquences sur la santé comme, par exemple, la survenue de cancers cutanés (Aubin F., 2001). Les filtres UV permettent d’assurer une protection dans les domaines UVA et/ou UVB. On en trouve dans les produits de protection solaire que le public utilise ponctuellement lors des expositions prolongées au soleil. -
Annex VI, Last Update: 02/08/2021
File creation date: 03/10/2021 Annex VI, Last update: 22/09/2021 LIST OF UV FILTERS ALLOWED IN COSMETIC PRODUCTS Substance identification Conditions Wording of Reference Maximum conditions of Product Type, concentration Update date number Chemical name / INN / XAN Name of Common Ingredients Glossary CAS Number EC Number Other use and body parts in ready for use warnings preparation 2 N,N,N-Trimethyl-4-(2-oxoborn-3-ylidenemethyl CAMPHOR BENZALKONIUM 52793-97-2 258-190-8 6% 15/10/2010 ) anilinium methyl sulphate METHOSULFATE 3 Benzoic acid, 2-hydroxy-, HOMOSALATE 118-56-9 204-260-8 10% 02/08/2021 3,3,5-trimethylcyclohexyl ester / Homosalate 4 2-Hydroxy-4-methoxybenzophenone / BENZOPHENONE-3 131-57-7 205-031-5 6% Reg (EU) Not more than Contains 02/08/2021 Oxybenzone 2017/238 of 10 0,5 % to protect Benzophenone-3 February 2017- product (1) date of formulation application from September 2017 6 2-Phenylbenzimidazole-5-sulphonic acid and its PHENYLBENZIMIDAZOLE SULFONIC 27503-81-7 248-502-0 8%(as acid) 08/03/2011 potassium, sodium and triethanolamine salts / ACID Ensulizole 7 3,3'-(1,4-Phenylenedimethylene) bis TEREPHTHALYLIDENE DICAMPHOR 92761-26-7 / 410-960-6 / - 10%(as acid) 26/10/2010 (7,7-dimethyl-2-oxobicyclo-[2.2.1] SULFONIC ACID 90457-82-2 hept-1-ylmethanesulfonic acid) and its salts / Ecamsule 8 1-(4-tert-Butylphenyl)-3-(4-methoxyphenyl) BUTYL 70356-09-1 274-581-6 5% 15/10/2010 propane-1,3-dione / Avobenzone METHOXYDIBENZOYLMETHANE 9 alpha-(2-Oxoborn-3-ylidene)toluene-4-sulphoni BENZYLIDENE CAMPHOR SULFONIC 56039-58-8 - 6%(as acid) -
Cutaneous Permeation and Penetration of Sunscreens: Formulation Strategies and in Vitro Methods
cosmetics Review Cutaneous Permeation and Penetration of Sunscreens: Formulation Strategies and In Vitro Methods Silvia Tampucci * ID , Susi Burgalassi ID , Patrizia Chetoni ID and Daniela Monti ID Department of Pharmacy, University of Pisa, 56126 Pisa, Italy; [email protected] (S.B.); [email protected] (P.C.); [email protected] (D.M.) * Correspondence: [email protected] Received: 1 November 2017; Accepted: 7 December 2017; Published: 25 December 2017 Abstract: Sunscreens are the most common products used for skin protection against the harmful effects of ultraviolet radiation. However, as frequent application is recommended, the use of large amount of sunscreens could reflect in possible systemic absorption and since these preparations are often applied on large skin areas, even low penetration rates can cause a significant amount of sunscreen to enter the body. An ideal sunscreen should have a high substantivity and should neither penetrate the viable epidermis, the dermis and the systemic circulation, nor in hair follicle. The research of methods to assess the degree of penetration of solar filters into the skin is nowadays even more important than in the past, due to the widespread use of nanomaterials and the new discoveries in cosmetic formulation technology. In the present paper, different in vitro studies, published in the last five years, have been reviewed, in order to focus the attention on the different methodological approaches employed to effectively assess the skin permeation and retention of sunscreens. Keywords: sunscreens; formulation; in vitro methods; cutaneous permeation; skin penetration 1. Introduction The detrimental effects of human exposure to ultraviolet (UV) radiation have been widely investigated and can be immediate, as in the case of sunburns, or long-term, causing, in most cases, the formation of oxidizing species responsible of photo-aging, immunosuppression and chronic effects such as photo carcinogenicity [1,2]. -
How to Overcome the New Challenges in Sun Care
Thannhausen, Germany, July 31, 2020 Thannhausen, Germany, | Volume 146 Volume | 7+8/20 home care 60 Years Sinner Circle: The Future powered by of Washing and Cleaning 7/8 2020 english How to Overcome the New Challenges skin care Positive Impact of Emulsifiers sun care in Sun Care on End-user Skin Benefits How to Overcome the New Challenges in Sun Care Natural-based 360° Approach for Optimized Formulations Sunscreen Diversity – more Options for Ingredients oral care How Polyurethane Film Formers Can Help A Natural Way to Treat Tooth Sensitivity Reduce the Impact on the Environment M. Sohn, S. Krus, M. Schnyder, S. Acker, M. Petersen-Thiery, S. Pawlowski, B. Herzog SOFW Journal 7+8/20 | Volume 146 | Thannhausen, Germany, July 31, 2020 personalpersonal care care | sun care From the UV filters under scrutiny, the widely used UVB fil- ters Ethylhexyl Methoxycinnamate (EHMC) and Octocrylene (OCR) are heavily discussed due to rising concerns regarding their safety profile for humans and for the environment. In Europe, legally approved UV filters are additionally assessed by the European Chemical Agency (ECHA) within the Regis- tration, Evaluation, Authorization, and Restriction of Chemi- cals (REACh) process, like all other industrial chemicals. Also, in the USA, the Food and Drug Administration (FDA) issued a proposed rule to put into effect a final monograph for over- the-counter sunscreen drug products [2]. In its proposal the © BASF’s Care Creations® FDA describes the conditions under which a sunscreen active is Generally Recognized as Safe and Effective (GRASE) and highlights the safety data gaps and additional required data for each already approved UV filter to be included in catego- How to Overcome the ry I, UV filters with a positive GRASE. -
EC No. 1223/2009 of the European Parliament and of the Council
2009R1223 — EN — 18.08.2015 — 009.001 — 1 This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents ►B REGULATION (EC) No 1223/2009 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 30 November 2009 on cosmetic products (recast) (Text with EEA relevance) (OJ L 342, 22.12.2009, p. 59) Amended by: Official Journal No page date ►M1 Commission Regulation (EU) No 344/2013 of 4 April 2013 L 114 1 25.4.2013 ►M2 Commission Regulation (EU) No 483/2013 of 24 May 2013 L 139 8 25.5.2013 ►M3 Commission Regulation (EU) No 658/2013 of 10 July 2013 L 190 38 11.7.2013 ►M4 Commission Regulation (EU) No 1197/2013 of 25 November 2013 L 315 34 26.11.2013 ►M5 Commission Regulation (EU) No 358/2014 of 9 April 2014 L 107 5 10.4.2014 ►M6 Commission Regulation (EU) No 866/2014 of 8 August 2014 L 238 3 9.8.2014 ►M7 Commission Regulation (EU) No 1003/2014 of 18 September 2014 L 282 1 26.9.2014 ►M8 Commission Regulation (EU) No 1004/2014 of 18 September 2014 L 282 5 26.9.2014 ►M9 Commission Regulation (EU) 2015/1190 of 20 July 2015 L 193 115 21.7.2015 ►M10 Commission Regulation (EU) 2015/1298 of 28 July 2015 L 199 22 29.7.2015 Corrected by: ►C1 Corrigendum, OJ L 142, 29.5.2013, p. 10 (344/2013) ►C2 Corrigendum, OJ L 254, 28.8.2014, p. -
Spatio-Temporal Trends of the UV Filter 2-Ethylhexyl-4-Methoxycinnamate
Nagorka and Dufek Environ Sci Eur (2021) 33:8 https://doi.org/10.1186/s12302-020-00448-w RESEARCH Open Access Under the infuence of regulations: spatio-temporal trends of the UV flter 2-Ethylhexyl-4-methoxycinnamate (EHMC) in German rivers Regine Nagorka* and Anja Dufek Abstract Background: Globally, 2-Ethylhexyl-4-methoxycinnamate (EHMC) is one of the most commonly used UV flters in sunscreen and personal care products. Due to its widespread usage, the occurrence of EHMC in the aquatic environ- ment has frequently been documented. In the EU, EHMC is listed under the European Community Rolling Action Plan (CoRAP) as suspected to be persistent, bioaccumulative, and toxic (PBT) and as a potential endocrine disruptor. It was included in the frst watch list under the Water Framework Directive (WFD) referring to a sediment PNEC of 200 µg/ kg dry weight (dw). In the light of the ongoing substance evaluation to refne the environmental risk assessment, the objective of this study was to obtain spatio-temporal trends for EHMC in freshwater. We analyzed samples of suspended particulate matter (SPM) retrieved from the German environmental specimen bank (ESB). The samples covered 13 sampling sites from major German rivers, including Rhine, Elbe, and Danube, and have been collected since mid-2000s. Results: Our results show decreasing concentrations of EHMC in annual SPM samples during the studied period. In the mid-2000s, the levels for EHMC ranged between 3.3 and 72 ng/g dw. The highest burden could be found in the Rhine tributary Saar. In 2017, we observed a maximum concentration ten times lower (7.9 ng/g dw in samples from the Saar). -
Patch Test Products and Reference Manual 2015
PATCH TEST PRODUCTS & REFERENCE MANUAL MANUAL REFERENCE & PRODUCTS TEST PATCH 4 World Leader in Patch Testing 2015 CHEMOTECHNIQUE DIAGNOSTICS CHEMOTECHNIQUE PATCH TEST PRODUCTS & REFERENCE MANUAL 2015 MODEMGATAN 9 | SE-235 39 VELLINGE |SWEDEN PHONE +46 40 466 077 | FAX +46 40 466 700 WWW.CHEMOTECHNIQUE.SE [email protected] | [email protected] ...for the diagnosis of contact allergy 2015 The complete range of products for Patch Testing A1 Foreword by Bo Niklasson, CEO First of all I would like to thank all our faithful customers for your support during the past year and also welcome our new distributors that have been appointed during the year. Chemotechnique Diagnostic’s 34 years of continuous growth and development has been the result of our belief in building strong and long term business relationships with our global network of distributors, combined with the ongoing support and contributions of our product-user base of physicians. Our commitment is to continue serving dermatology in future years... maintaining our leadership position. During the past year we have invested in new state of the art equipment in both the analytical and production sector and developed a closed loop system in the production of haptens. When looking at our website you will note that we have made it possible also for patients to freely access our database of extensive information regarding the haptens and being able to print information sheets. We have also changed the site to be adapted to mobile platforms such as mobile phones, iPads and similar devices. There will as always be additions and amendments in our range and these are found at the end of the Patch Test Products & Reference Manual. -
Methods to Evaluate the Water Resistance of Sunscreens
ORIGINAL ARTICLES LPiC, MMS, EA21601, Laboratoire de Pharmacie galénique2, Faculty of Pharmacy, Université de Nantes, France Comparison of two in vitro methods to evaluate the water resistance of sunscreens C. Cheignon 1, C. Couteau 1, A. Billon-Chabaud 2, E. Marques Da Silva 1, E. Paparis 1, L. J. M. Coiffard 1 Received April 1, 2011, accepted May 6, 2011 L. J. M. Coiffard, Université de Nantes, Nantes Atlantique Universités, LPiC, MMS, EA2160, Faculty of Pharmacy, 1 rue G. Veil – BP 53508, Nantes, F-44000 France [email protected] Pharmazie 67: 116–119 (2012) doi: 10.1691/ph.2012.1048 For a long time, the water resistance of sunscreens has been determined in vivo, according to Colipa’s (Comité de Liaison des Industries de la Parfumerie) procedure. This method is not so ethical as healthy volunteers are irradiated, and can be replaced by an in vitro method which is easy and quick to perform. The objective of this work was to correlate the experimental device proposed by Choquenet et al. and the dissolutest (Sotax® AT6). This equipment is used in the pharmaceutical industry to control the tablets. The experimental conditions have been fixed to correlate the results obtained with both methods. The stirring speed for the dissolutest was fixed at 75 rpm, which is the speed value recommended by the European Pharmacopeia to study the dissolution over time of tablets. 1. Introduction Table 1: Efficacy measured of the formulations tested To stay as long as possible on the surface of the skin, a sun- Bioblock IK mixer Sotax care product should be water resistant, in order to resist bathing ± ± as well as sweat (Leroy and Deschamps 1986; Moloney et al. -
Photoprotection
Photoprotection Review Article Photoprotection Authors: ABSTRACT Gabriel Teixeira Gontijo1 2 Maria Cecília Carvalho Pugliesi Introduction: Incidence of skin cancer has increased signifi cantly in recent decades, Fernanda Mendes Araújo3 corresponding to a public health problem in many countries. Skin is the organ most affected 1Professor of Dermatology – by the deleterious effects of ultraviolet radiation and the association between sun exposure Universidade Federal de Minas Gerais; Preceptor of the and skin cancer is well-documented. Objective: To conduct a comprehensive review of the Dermatologic Surgery Department main photoprotection measures. Method: We conducted searches on MEDLINE from June at Hospital das Clinicas – 22 through August 18. Descriptive studies, review, and comparative studies were analyzed Universidade Federal de Minas Gerais together. Results: Eleven articles about a review of photoprotection, effects of ultraviolet 2Resident in Dermatology, UFMG radiation on the skin, prevalence of the use of sunscreens, and behavioral measures among 3 MD adults and adolescents were reported were selected. Conclusions: The use of broad-spectrum Correspondence to: sunscreens, besides simple behavioral measures, appears to have a major impact on prevention Gabriel Gontijo of skin cancer. Praça da Bandeira, nº 170, 4º andar Keywords: ultraviolet light, sunlight, ultraviolet fi lters, squamous cell carcinoma, basal cell Bairro Mangabeiras – Belo Horizonte – MG carcinoma, melanoma, vitamin D, stability of cosmetics. CEP: 30130-050 Tel: -
(12) United States Patent (10) Patent No.: US 9,655,825 B2 Youssef Et Al
US0096.55825B2 (12) United States Patent (10) Patent No.: US 9,655,825 B2 Youssef et al. (45) Date of Patent: *May 23, 2017 (54) SUNSCREEN COMPOSITION CONTAINING (56) References Cited HIGH LEVELS OF LIPOSOLUBLEUV FILTERS U.S. PATENT DOCUMENTS 5,599,533 A 2/1997 Stepniewski et al. (71) Applicant: L’OREAL, Paris (FR) 6,548,074 B1 4/2003 Mohammadi 7,772,214 B2 8, 2010 Vatter et al. (72) Inventors: Sara Robyn Muenz Youssef, 8,329,200 B2 12/2012 Bauer et al. 8,592,547 B2 11/2013 Sakuta et al. Middlesex, NJ (US); Catherine Chiou, 2007/0274932 A1 11/2007 Suginaka et al. Saddle Brook, NJ (US); Angelike A. 2007/0297997 A1 12/2007 Tanner Galdi, Westfield, NJ (US) 2008, OO38360 A1 2/2008 Zukowski et al. 2010/0092408 A1 4/2010 Breyfogle et al. 2013,0230474 A1 9/2013 Tanner (73) Assignee: L'Oreal, Paris (FR) 2013,034531.6 A1 12/2013 Chiou (*) Notice: Subject to any disclaimer, the term of this patent is extended or adjusted under 35 FOREIGN PATENT DOCUMENTS U.S.C. 154(b) by 0 days. DE 102O08060656 A1 6, 2010 EP O813403 A1 12, 1997 This patent is Subject to a terminal dis EP 1598.045 A2 11/2005 claimer. EP 2334283 A2 6, 2011 JP 11315009 A 11, 1999 (21) Appl. No.: 14/744,771 WO 2013 192004 A2 12/2013 (22) Filed: Jun. 19, 2015 OTHER PUBLICATIONS (65) Prior Publication Data Agache et al.(Measuring the Skin; 2004; Springer Science & Business Media: p. 29).* US 2016/0367453 A1 Dec.